PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34273501-6	2021	Neuroprotection was lost with RET inhibition by vandetanib or GSK3179106, which also caused neuron loss in untreated controls.	vandetanib	48-58	ret proto-oncogene	Rattus norvegicus	30-33	
28840516-3	2018	Our goal was to assess the effects of administering a selective tyrosine kinase inhibitor (vandetanib) that blocks VEGFR2 and RET receptors in a preclinical model of PD.	vandetanib	91-101	ret proto-oncogene	Rattus norvegicus	126-129	
23426662-6	2013	TNFalpha or IL-1beta sharply increased both mRNA and protein for GDNF, while the neurotrophic effects of TNFalpha or IL-1beta were blocked by the RET-receptor blocker vandetanib.	vandetanib	167-177	ret proto-oncogene	Rattus norvegicus	146-149